485 related articles for article (PubMed ID: 18342527)
1. Pattern of axonal injury in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis: implications for multiple sclerosis.
Herrero-Herranz E; Pardo LA; Gold R; Linker RA
Neurobiol Dis; 2008 May; 30(2):162-73. PubMed ID: 18342527
[TBL] [Abstract][Full Text] [Related]
2. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions.
Kornek B; Storch MK; Weissert R; Wallstroem E; Stefferl A; Olsson T; Linington C; Schmidbauer M; Lassmann H
Am J Pathol; 2000 Jul; 157(1):267-76. PubMed ID: 10880396
[TBL] [Abstract][Full Text] [Related]
3. Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis.
Recks MS; Stormanns ER; Bader J; Arnhold S; Addicks K; Kuerten S
Clin Immunol; 2013 Oct; 149(1):32-45. PubMed ID: 23899992
[TBL] [Abstract][Full Text] [Related]
4. Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat.
Papadopoulos D; Pham-Dinh D; Reynolds R
Exp Neurol; 2006 Feb; 197(2):373-85. PubMed ID: 16337942
[TBL] [Abstract][Full Text] [Related]
5. Bax-ablation attenuates experimental autoimmune encephalomyelitis in mice.
Lev N; Barhum Y; Melamed E; Offen D
Neurosci Lett; 2004 Apr; 359(3):139-42. PubMed ID: 15050683
[TBL] [Abstract][Full Text] [Related]
6. Axonal loss and gray matter pathology as a direct result of autoimmunity to neurofilaments.
Huizinga R; Gerritsen W; Heijmans N; Amor S
Neurobiol Dis; 2008 Dec; 32(3):461-70. PubMed ID: 18804534
[TBL] [Abstract][Full Text] [Related]
7. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
Aharoni R; Vainshtein A; Stock A; Eilam R; From R; Shinder V; Arnon R
J Autoimmun; 2011 Nov; 37(3):228-41. PubMed ID: 21752599
[TBL] [Abstract][Full Text] [Related]
8. Validation of a novel biomarker for acute axonal injury in experimental autoimmune encephalomyelitis.
Gresle MM; Shaw G; Jarrott B; Alexandrou EN; Friedhuber A; Kilpatrick TJ; Butzkueven H
J Neurosci Res; 2008 Dec; 86(16):3548-55. PubMed ID: 18709652
[TBL] [Abstract][Full Text] [Related]
9. Disruption of oligodendrocyte gap junctions in experimental autoimmune encephalomyelitis.
Markoullis K; Sargiannidou I; Gardner C; Hadjisavvas A; Reynolds R; Kleopa KA
Glia; 2012 Jul; 60(7):1053-66. PubMed ID: 22461072
[TBL] [Abstract][Full Text] [Related]
10. Axonal and neuronal pathology in multiple sclerosis: what have we learnt from animal models.
Lassmann H
Exp Neurol; 2010 Sep; 225(1):2-8. PubMed ID: 19840788
[TBL] [Abstract][Full Text] [Related]
11. EAE in beta-2 microglobulin-deficient mice: axonal damage is not dependent on MHC-I restricted immune responses.
Linker RA; Rott E; Hofstetter HH; Hanke T; Toyka KV; Gold R
Neurobiol Dis; 2005; 19(1-2):218-28. PubMed ID: 15837577
[TBL] [Abstract][Full Text] [Related]
12. Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE.
Eltayeb S; Berg AL; Lassmann H; Wallström E; Nilsson M; Olsson T; Ericsson-Dahlstrand A; Sunnemark D
J Neuroinflammation; 2007 May; 4():14. PubMed ID: 17484785
[TBL] [Abstract][Full Text] [Related]
13. Transient axonal injury in the absence of demyelination: a correlate of clinical disease in acute experimental autoimmune encephalomyelitis.
Aboul-Enein F; Weiser P; Höftberger R; Lassmann H; Bradl M
Acta Neuropathol; 2006 Jun; 111(6):539-47. PubMed ID: 16718350
[TBL] [Abstract][Full Text] [Related]
14. Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice.
Berard JL; Wolak K; Fournier S; David S
Glia; 2010 Mar; 58(4):434-45. PubMed ID: 19780195
[TBL] [Abstract][Full Text] [Related]
15. Gene expression analysis of normal appearing brain tissue in an animal model for multiple sclerosis revealed grey matter alterations, but only minor white matter changes.
Zeis T; Kinter J; Herrero-Herranz E; Weissert R; Schaeren-Wiemers N
J Neuroimmunol; 2008 Dec; 205(1-2):10-9. PubMed ID: 18950873
[TBL] [Abstract][Full Text] [Related]
16. A new focal EAE model of cortical demyelination: multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination.
Merkler D; Ernsting T; Kerschensteiner M; Brück W; Stadelmann C
Brain; 2006 Aug; 129(Pt 8):1972-83. PubMed ID: 16714315
[TBL] [Abstract][Full Text] [Related]
17. Enhanced visualization of axonopathy in EAE using thy1-YFP transgenic mice.
Bannerman PG; Hahn A
J Neurol Sci; 2007 Sep; 260(1-2):23-32. PubMed ID: 17493638
[TBL] [Abstract][Full Text] [Related]
18. Relationship of acute axonal damage, Wallerian degeneration, and clinical disability in multiple sclerosis.
Singh S; Dallenga T; Winkler A; Roemer S; Maruschak B; Siebert H; Brück W; Stadelmann C
J Neuroinflammation; 2017 Mar; 14(1):57. PubMed ID: 28302146
[TBL] [Abstract][Full Text] [Related]
19. Pathological findings in rats with experimental allergic encephalomyelitis.
Dong M; Liu R; Guo L; Li C; Tan G
APMIS; 2008 Nov; 116(11):972-84. PubMed ID: 19132994
[TBL] [Abstract][Full Text] [Related]
20. Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE.
Black JA; Liu S; Hains BC; Saab CY; Waxman SG
Brain; 2006 Dec; 129(Pt 12):3196-208. PubMed ID: 16931536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
